Regulation detail

Fla. Admin. Code r. 65E-16.004

Up to date
Ask Ariadne
SR
Fla. Admin. Code r. 65E-16.004 removed

65E-16.004 Sanctions

Jurisdiction: FL Agency: Florida Department of Children and Families
OUTPATIENT (60%)
Plain-English summary

This rule establishes the enforcement and sanction framework for providers participating in Florida's Indigent Psychiatric Medication Program (IPMP). It outlines a tiered response to noncompliance: non-threatening violations trigger a notice of noncompliance and a corrective action plan, while violations threatening health or safety trigger an immediate moratorium on IPMP prescriptions and a mandatory corrective action plan ensuring continued medication access. Providers may be permanently terminated from the program for fraud, patient harm, or patterns of deficient performance, and terminated providers are barred from reapplying for one year.

View official source
Regulation text
65E-16.004 Sanctions.
(1) If an IPMP provider is not in compliance with the requirements in Chapter 65E-16 F.A.C. and Chapters 465 and 499, Part I, F.S., and the violation does not present a threat to the health, safety, or welfare of an individual or the public, the Department shall:
(a) Provide a notice of noncompliance to the provider as the first enforcement action taken; and 
(b) Require a corrective action plan from the Managing Entity and the IPMP provider within 10 business days from receipt of the notice of noncompliance. The severity of the noncompliance may affect the period of time allowed for correction, but in no event shall the corrective action period exceed 90 days. 
(2) When the violation does present a threat to the health, safety, or welfare of an individual or the public:
(a) The Department will require a corrective action plan from the Managing Entity and the IPMP provider within 10 business days from receipt of the notice of noncompliance. The corrective action plan must include a procedure to ensure that individuals who participate in IPMP continue to have access to psychiatric medications; and
(b) The Department will impose an immediate moratorium on IPMP prescriptions; and
(c) In no event shall the corrective action period exceed 90 days. 
(3) Notice of the moratorium shall be posted and visible to the public at the location of the provider until the action is lifted.
(4) Each Managing Entity will terminate participation of an IPMP provider from this Program for:
(a) False representation or omission of information relevant to approving a provider to participate in the Program. 
(b) An intentional or negligent act materially affecting the health or safety of an individual receiving IPMP services from the provider.
(c) A demonstrated pattern of deficient performance.
(5) If an IPMP provider’s contract is terminated for cause by the Managing Entity, or if the provider is terminated from participation in the Program, the IPMP provider is barred from submitting any request to participate in this Program to the Managing Entity for a period of one (1) year after the termination.
Rulemaking Authority 394.676(2) FS. Law Implemented 394.676 FS. History–New 9-19-19.